Unknown

Dataset Information

0

An intrinsic, label-free signal for identifying stem cell-derived cardiomyocyte subtype.


ABSTRACT: Human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes have many promising applications, including the regeneration of injured heart muscles, cardiovascular disease modeling, and drug cardiotoxicity screening. Current differentiation protocols yield a heterogeneous cell population that includes pluripotent stem cells and different cardiac subtypes (pacemaking and contractile cells). The ability to purify these cells and obtain well-defined, controlled cell compositions is important for many downstream applications; however, there is currently no established and reliable method to identify hiPSC-derived cardiomyocytes and their subtypes. Here, we demonstrate that second harmonic generation (SHG) signals generated directly from the myosin rod bundles can be a label-free, intrinsic optical marker for identifying hiPSC-derived cardiomyocytes. A direct correlation between SHG signal intensity and cardiac subtype is observed, with pacemaker-like cells typically exhibiting ~70% less signal strength than atrial- and ventricular-like cardiomyocytes. These findings suggest that pacemaker-like cells can be separated from the heterogeneous population by choosing an SHG intensity threshold criteria. This work lays the foundation for developing an SHG-based high-throughput flow sorter for purifying hiPSC-derived cardiomyocytes and their subtypes.

SUBMITTER: Chang CW 

PROVIDER: S-EPMC7302059 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

An intrinsic, label-free signal for identifying stem cell-derived cardiomyocyte subtype.

Chang Che-Wei CW   Kao Hillary K J HKJ   Yechikov Sergey S   Lieu Deborah K DK   Chan James W JW  

Stem cells (Dayton, Ohio) 20191209 3


Human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes have many promising applications, including the regeneration of injured heart muscles, cardiovascular disease modeling, and drug cardiotoxicity screening. Current differentiation protocols yield a heterogeneous cell population that includes pluripotent stem cells and different cardiac subtypes (pacemaking and contractile cells). The ability to purify these cells and obtain well-defined, controlled cell compositions is important f  ...[more]

Similar Datasets

| S-EPMC3556464 | biostudies-literature
| S-EPMC3080969 | biostudies-literature
| S-EPMC8319125 | biostudies-literature
| S-EPMC3153440 | biostudies-literature
2018-11-28 | GSE81585 | GEO
| S-EPMC3704625 | biostudies-literature
| S-EPMC6590086 | biostudies-literature
| S-EPMC8354591 | biostudies-literature
| S-EPMC7067786 | biostudies-literature
| S-EPMC8448341 | biostudies-literature